Government Consulting
| Year | Client | Period | Income | Expenses | Doc |
|---|---|---|---|---|---|
| 2026 | NANODX |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$30,000 | — | |
| 2026 | STUDENTS FOR LIFE OF AMERICA |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | — | |
| 2026 | NANODX |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$30,000 | — | |
| 2025 | STUDENTS FOR LIFE OF AMERICA |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | — | |
| 2025 | NANODX |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$30,000 | — | |
| 2025 | STUDENTS FOR LIFE OF AMERICA |
4th Quarter (Oct 1 - Dec 31) Registration |
— | — | |
| 2025 | NANODX |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$30,000 | — | |
| 2025 | NANODX |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$30,000 | — | |
| 2025 | NANODX |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$30,000 | — | |
| 2024 | NANODX |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$30,000 | — |
| Client | Filings | Total Income |
|---|---|---|
| NANODX | 27 | $605,000 |
| AMICUS THERAPEUTICS, INC. | 18 | $240,000 |
| APELLIS PHARMACUETICALS | 13 | $200,000 |
| TAYSHA GENE THERAPIES | 13 | $110,000 |
| PARATEK PHARMACEUTICALS | 8 | $216,000 |
| STUDENTS FOR LIFE OF AMERICA | 3 | — |
| Name | Disclosed Prior Position |
|---|---|
| JEFFREY ANDERS | |
| MICHAEL J EGING | |
| KELSEY HADDOW |